Liquid Biopsy

A Global Strategic Business Report

MCP13050

RESEARCH DASHBOARD

OCT 2025

RELEASE DATE

1784

EXECUTIVE POOL

5850

PRICE

321

EXPERT INPUTS

42

COMPANIES

123

DATA TABLES

194

PAGES

9

EDITION

WHAT'S BEHIND OUR DATA?

140857226

DOMAIN TRANSCRIPTS

6080276

BRANDS TRACKED

1729341

FEATURED COMPANIES

22574

TOPICS COVERED

82719

MARKET SEGMENTS

91

KEY INDUSTRIES

1574

CURATION TEAM

4761909

DECISION MAKERS

EXECUTIVE ENGAGEMENTS BY TIER (689)

43

CXO

120

VICE PRESIDENT

312

DIRECTOR

107

MANAGER

107

MARKETING

REQUEST FULL-STACK INDEX Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription

The Economist
MIT Technology Review
Harvard Business Review

Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.

MARKETGLASS

BASIC

Annual Prepaid Subscription
Single-User
10,000 Data Room Credits/Month
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use MarketGlass^TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.

PREMIUM

Annual Prepaid Subscription
One Research Project With One Complimentary Update/Year
10-User License
10-User Peer-to-Peer Collaborative Features
200 Domain Expert Insights (With Name, Company, and Date)
50,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

ENTERPRISE

Annual Prepaid Subscription
Four Research Projects With One Complimentary Update/Year
25-User License
25-User Peer-to-Peer Collaborative Engagements
500 Domain Expert Insights (With Name, Company, and Date)
150,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

HIGHLIGHTS & REPORT INDEX

Global Liquid Biopsy Market to Reach US$17.1 Billion by 2030

The global market for Liquid Biopsy estimated at US$6.3 Billion in the year 2024, is expected to reach US$17.1 Billion by 2030, growing at a CAGR of 17.9% over the analysis period 2024-2030. Assay Kits, one of the segments analyzed in the report, is expected to record a 18.0% CAGR and reach US$12.8 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 16.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.8 Billion While China is Forecast to Grow at 17.2% CAGR

The Liquid Biopsy market in the U.S. is estimated at US$1.8 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2030 trailing a CAGR of 17.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.6% and 15.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.1% CAGR.

Global Liquid Biopsy Market - Key Trends & Drivers Summarized

Why Is Liquid Biopsy Revolutionizing Cancer Diagnosis and Treatment?

Liquid biopsy is revolutionizing the field of cancer diagnosis and treatment by offering a non-invasive, accurate, and real-time method to detect and monitor cancer. Unlike traditional tissue biopsies, which require surgical procedures to obtain samples, liquid biopsies involve analyzing a blood sample to detect circulating tumor cells (CTCs), cell-free DNA (cfDNA), or other biomarkers associated with cancer. This approach allows for the early detection of cancer, monitoring of disease progression, and assessment of treatment efficacy, all with minimal discomfort to the patient. The ability of liquid biopsies to provide comprehensive insights into the genetic makeup of tumors is transforming personalized medicine, enabling oncologists to tailor treatments to individual patients` needs more effectively. As the demand for less invasive, more accurate diagnostic tools grows, liquid biopsy is rapidly gaining acceptance as a valuable tool in oncology.

How Are Technological Advancements Driving the Liquid Biopsy Market?

Technological advancements are playing a crucial role in driving the growth and adoption of liquid biopsy, making it more accurate, accessible, and informative. Innovations in next-generation sequencing (NGS) and digital PCR (Polymerase Chain Reaction) technologies are enhancing the sensitivity and specificity of liquid biopsies, allowing for the detection of minute amounts of cancer-related biomarkers in the blood. These advancements are enabling the identification of a broader range of genetic mutations, providing deeper insights into tumor biology and treatment response. Additionally, the development of advanced bioinformatics tools is improving the analysis and interpretation of liquid biopsy data, facilitating more precise and personalized treatment decisions. The ongoing refinement of liquid biopsy assays is also expanding their application beyond oncology, with potential uses in monitoring organ transplant rejection, detecting infectious diseases, and assessing prenatal genetic conditions. These technological innovations are making liquid biopsy a more powerful and versatile tool in precision medicine.

What Market Trends Are Shaping the Demand for Liquid Biopsy?

Several key market trends are shaping the demand for liquid biopsy, including the increasing emphasis on personalized medicine, the growing adoption of non-invasive diagnostic tools, and the expansion of liquid biopsy applications beyond oncology. As personalized medicine continues to gain traction, there is a growing need for diagnostic tools that can provide detailed genetic information to guide targeted therapies. Liquid biopsy`s ability to offer real-time insights into tumor genetics makes it a valuable asset in this approach. The trend towards non-invasive diagnostics is also driving demand for liquid biopsy, as patients and healthcare providers seek less invasive, more comfortable alternatives to traditional tissue biopsies. Additionally, the potential for liquid biopsy to be used in other areas of medicine, such as transplant monitoring and infectious disease detection, is expanding its market opportunities. The increasing use of liquid biopsy in clinical trials and drug development is further contributing to its growth, as it provides a valuable tool for monitoring treatment response and disease progression in real-time.

What Is Driving the Growth in the Liquid Biopsy Market?

The growth in the liquid biopsy market is driven by several factors. The rising incidence of cancer worldwide and the growing demand for less invasive diagnostic methods are major drivers, as liquid biopsy offers a more patient-friendly alternative to traditional biopsies. Technological advancements in genomics and molecular diagnostics are enhancing the accuracy and utility of liquid biopsy, making it a more attractive option for both clinicians and patients. The increasing adoption of personalized medicine and the need for real-time monitoring of cancer progression and treatment response are also contributing to the market`s expansion. Additionally, the broadening of liquid biopsy applications beyond oncology, such as in transplant monitoring and prenatal testing, is creating new opportunities for growth. The growing number of clinical trials and research studies utilizing liquid biopsy is further supporting market development, as these efforts continue to validate and expand the potential uses of this innovative technology.

SCOPE OF STUDY

The report analyzes the Liquid Biopsy market by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Assay Kits, Instruments, Services); Technology (Multi Gene Parallel Analysis, Single Gene Analysis); Application (Cancer, Non-Cancer); End-Use (Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers, Other End-Uses).

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World..

SELECT PLAYERS

Apostle Inc;Biocept, Inc.;BioChain Institute, Inc.;Biolidics Ltd.;CatchGene;Elphogene;F. Hoffmann-La Roche AG;Gencurix, Inc. ;Genomill Health;Guardant Health, Inc.

AI INTEGRATIONS

We’re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights

Tariff Impact on Global Supply Chain Patterns

Liquid Biopsy – Global Key Competitors Percentage Market Share in 2024 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for 42 Players Worldwide in 2024 (E)

Global Economic Update

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Expanding Clinical Applications Propel Growth in the Liquid Biopsy Market

Advancements in Circulating Tumor DNA (ctDNA) Technologies Drive Diagnostic Innovations

Integration of Liquid Biopsy with Precision Oncology Enhances Treatment Personalization

Rising Prevalence of Cancer Worldwide Boosts Demand for Non-Invasive Diagnostic Methods

Technological Breakthroughs in Single-Cell Analysis Expand Capabilities of Liquid Biopsy

FDA Approvals Accelerate Adoption of Liquid Biopsy Tests in Clinical Settings

Collaborations between Biotech Firms and Academic Institutions Fuel Research and Development

Growing Investment in Personalized Medicine Spurs Development of Targeted Therapies Using Liquid Biopsy

Market Challenges Posed by Sensitivity and Specificity Concerns in Early Cancer Detection

Impact of Artificial Intelligence on Enhancing Accuracy and Speed of Liquid Biopsy Analysis

Insurance Coverage and Reimbursement Policies Shape the Liquid Biopsy Landscape

4. GLOBAL MARKET PERSPECTIVE

World Recent Past, Current & Future Analysis for Assay Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Assay Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Multi Gene Parallel Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Multi Gene Parallel Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Single Gene Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Single Gene Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Non-Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Non-Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Reference Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Hospitals & Physician Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Hospitals & Physician Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Academic & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Academic & Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

World Liquid Biopsy Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

World Recent Past, Current & Future Analysis for Liquid Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World 6-Year Perspective for Liquid Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES

Liquid Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)

USA Recent Past, Current & Future Analysis for Liquid Biopsy by Offering - Assay Kits, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA 6-Year Perspective for Liquid Biopsy by Offering - Percentage Breakdown of Value Sales for Assay Kits, Instruments and Services for the Years 2025 & 2030

USA Recent Past, Current & Future Analysis for Liquid Biopsy by Technology - Multi Gene Parallel Analysis and Single Gene Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA 6-Year Perspective for Liquid Biopsy by Technology - Percentage Breakdown of Value Sales for Multi Gene Parallel Analysis and Single Gene Analysis for the Years 2025 & 2030

USA Recent Past, Current & Future Analysis for Liquid Biopsy by Application - Cancer and Non-Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA 6-Year Perspective for Liquid Biopsy by Application - Percentage Breakdown of Value Sales for Cancer and Non-Cancer for the Years 2025 & 2030

USA Recent Past, Current & Future Analysis for Liquid Biopsy by End-Use - Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA 6-Year Perspective for Liquid Biopsy by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses for the Years 2025 & 2030

CANADA

Canada Recent Past, Current & Future Analysis for Liquid Biopsy by Offering - Assay Kits, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada 6-Year Perspective for Liquid Biopsy by Offering - Percentage Breakdown of Value Sales for Assay Kits, Instruments and Services for the Years 2025 & 2030

Canada Recent Past, Current & Future Analysis for Liquid Biopsy by Technology - Multi Gene Parallel Analysis and Single Gene Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada 6-Year Perspective for Liquid Biopsy by Technology - Percentage Breakdown of Value Sales for Multi Gene Parallel Analysis and Single Gene Analysis for the Years 2025 & 2030

Canada Recent Past, Current & Future Analysis for Liquid Biopsy by Application - Cancer and Non-Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada 6-Year Perspective for Liquid Biopsy by Application - Percentage Breakdown of Value Sales for Cancer and Non-Cancer for the Years 2025 & 2030

Canada Recent Past, Current & Future Analysis for Liquid Biopsy by End-Use - Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada 6-Year Perspective for Liquid Biopsy by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses for the Years 2025 & 2030

JAPAN

Liquid Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)

Japan Recent Past, Current & Future Analysis for Liquid Biopsy by Offering - Assay Kits, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan 6-Year Perspective for Liquid Biopsy by Offering - Percentage Breakdown of Value Sales for Assay Kits, Instruments and Services for the Years 2025 & 2030

Japan Recent Past, Current & Future Analysis for Liquid Biopsy by Technology - Multi Gene Parallel Analysis and Single Gene Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan 6-Year Perspective for Liquid Biopsy by Technology - Percentage Breakdown of Value Sales for Multi Gene Parallel Analysis and Single Gene Analysis for the Years 2025 & 2030

Japan Recent Past, Current & Future Analysis for Liquid Biopsy by Application - Cancer and Non-Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan 6-Year Perspective for Liquid Biopsy by Application - Percentage Breakdown of Value Sales for Cancer and Non-Cancer for the Years 2025 & 2030

Japan Recent Past, Current & Future Analysis for Liquid Biopsy by End-Use - Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan 6-Year Perspective for Liquid Biopsy by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses for the Years 2025 & 2030

CHINA

Liquid Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)

China Recent Past, Current & Future Analysis for Liquid Biopsy by Offering - Assay Kits, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China 6-Year Perspective for Liquid Biopsy by Offering - Percentage Breakdown of Value Sales for Assay Kits, Instruments and Services for the Years 2025 & 2030

China Recent Past, Current & Future Analysis for Liquid Biopsy by Technology - Multi Gene Parallel Analysis and Single Gene Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China 6-Year Perspective for Liquid Biopsy by Technology - Percentage Breakdown of Value Sales for Multi Gene Parallel Analysis and Single Gene Analysis for the Years 2025 & 2030

China Recent Past, Current & Future Analysis for Liquid Biopsy by Application - Cancer and Non-Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China 6-Year Perspective for Liquid Biopsy by Application - Percentage Breakdown of Value Sales for Cancer and Non-Cancer for the Years 2025 & 2030

China Recent Past, Current & Future Analysis for Liquid Biopsy by End-Use - Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China 6-Year Perspective for Liquid Biopsy by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses for the Years 2025 & 2030

EUROPE

Liquid Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)

Europe Recent Past, Current & Future Analysis for Liquid Biopsy by Offering - Assay Kits, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Liquid Biopsy by Offering - Percentage Breakdown of Value Sales for Assay Kits, Instruments and Services for the Years 2025 & 2030

Europe Recent Past, Current & Future Analysis for Liquid Biopsy by Technology - Multi Gene Parallel Analysis and Single Gene Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Liquid Biopsy by Technology - Percentage Breakdown of Value Sales for Multi Gene Parallel Analysis and Single Gene Analysis for the Years 2025 & 2030

Europe Recent Past, Current & Future Analysis for Liquid Biopsy by Application - Cancer and Non-Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Liquid Biopsy by Application - Percentage Breakdown of Value Sales for Cancer and Non-Cancer for the Years 2025 & 2030

Europe Recent Past, Current & Future Analysis for Liquid Biopsy by End-Use - Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Liquid Biopsy by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses for the Years 2025 & 2030

Europe Recent Past, Current & Future Analysis for Liquid Biopsy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Europe 6-Year Perspective for Liquid Biopsy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030

FRANCE

Liquid Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)

France Recent Past, Current & Future Analysis for Liquid Biopsy by Offering - Assay Kits, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France 6-Year Perspective for Liquid Biopsy by Offering - Percentage Breakdown of Value Sales for Assay Kits, Instruments and Services for the Years 2025 & 2030

France Recent Past, Current & Future Analysis for Liquid Biopsy by Technology - Multi Gene Parallel Analysis and Single Gene Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France 6-Year Perspective for Liquid Biopsy by Technology - Percentage Breakdown of Value Sales for Multi Gene Parallel Analysis and Single Gene Analysis for the Years 2025 & 2030

France Recent Past, Current & Future Analysis for Liquid Biopsy by Application - Cancer and Non-Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France 6-Year Perspective for Liquid Biopsy by Application - Percentage Breakdown of Value Sales for Cancer and Non-Cancer for the Years 2025 & 2030

France Recent Past, Current & Future Analysis for Liquid Biopsy by End-Use - Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France 6-Year Perspective for Liquid Biopsy by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses for the Years 2025 & 2030

GERMANY

Liquid Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)

Germany Recent Past, Current & Future Analysis for Liquid Biopsy by Offering - Assay Kits, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany 6-Year Perspective for Liquid Biopsy by Offering - Percentage Breakdown of Value Sales for Assay Kits, Instruments and Services for the Years 2025 & 2030

Germany Recent Past, Current & Future Analysis for Liquid Biopsy by Technology - Multi Gene Parallel Analysis and Single Gene Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany 6-Year Perspective for Liquid Biopsy by Technology - Percentage Breakdown of Value Sales for Multi Gene Parallel Analysis and Single Gene Analysis for the Years 2025 & 2030

Germany Recent Past, Current & Future Analysis for Liquid Biopsy by Application - Cancer and Non-Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany 6-Year Perspective for Liquid Biopsy by Application - Percentage Breakdown of Value Sales for Cancer and Non-Cancer for the Years 2025 & 2030

Germany Recent Past, Current & Future Analysis for Liquid Biopsy by End-Use - Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany 6-Year Perspective for Liquid Biopsy by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses for the Years 2025 & 2030

ITALY

Italy Recent Past, Current & Future Analysis for Liquid Biopsy by Offering - Assay Kits, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy 6-Year Perspective for Liquid Biopsy by Offering - Percentage Breakdown of Value Sales for Assay Kits, Instruments and Services for the Years 2025 & 2030

Italy Recent Past, Current & Future Analysis for Liquid Biopsy by Technology - Multi Gene Parallel Analysis and Single Gene Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy 6-Year Perspective for Liquid Biopsy by Technology - Percentage Breakdown of Value Sales for Multi Gene Parallel Analysis and Single Gene Analysis for the Years 2025 & 2030

Italy Recent Past, Current & Future Analysis for Liquid Biopsy by Application - Cancer and Non-Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy 6-Year Perspective for Liquid Biopsy by Application - Percentage Breakdown of Value Sales for Cancer and Non-Cancer for the Years 2025 & 2030

Italy Recent Past, Current & Future Analysis for Liquid Biopsy by End-Use - Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy 6-Year Perspective for Liquid Biopsy by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses for the Years 2025 & 2030

UNITED KINGDOM

Liquid Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)

UK Recent Past, Current & Future Analysis for Liquid Biopsy by Offering - Assay Kits, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK 6-Year Perspective for Liquid Biopsy by Offering - Percentage Breakdown of Value Sales for Assay Kits, Instruments and Services for the Years 2025 & 2030

UK Recent Past, Current & Future Analysis for Liquid Biopsy by Technology - Multi Gene Parallel Analysis and Single Gene Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK 6-Year Perspective for Liquid Biopsy by Technology - Percentage Breakdown of Value Sales for Multi Gene Parallel Analysis and Single Gene Analysis for the Years 2025 & 2030

UK Recent Past, Current & Future Analysis for Liquid Biopsy by Application - Cancer and Non-Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK 6-Year Perspective for Liquid Biopsy by Application - Percentage Breakdown of Value Sales for Cancer and Non-Cancer for the Years 2025 & 2030

UK Recent Past, Current & Future Analysis for Liquid Biopsy by End-Use - Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK 6-Year Perspective for Liquid Biopsy by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses for the Years 2025 & 2030

REST OF EUROPE

Rest of Europe Recent Past, Current & Future Analysis for Liquid Biopsy by Offering - Assay Kits, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe 6-Year Perspective for Liquid Biopsy by Offering - Percentage Breakdown of Value Sales for Assay Kits, Instruments and Services for the Years 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Liquid Biopsy by Technology - Multi Gene Parallel Analysis and Single Gene Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe 6-Year Perspective for Liquid Biopsy by Technology - Percentage Breakdown of Value Sales for Multi Gene Parallel Analysis and Single Gene Analysis for the Years 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Liquid Biopsy by Application - Cancer and Non-Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe 6-Year Perspective for Liquid Biopsy by Application - Percentage Breakdown of Value Sales for Cancer and Non-Cancer for the Years 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Liquid Biopsy by End-Use - Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe 6-Year Perspective for Liquid Biopsy by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses for the Years 2025 & 2030

ASIA-PACIFIC

Liquid Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)

Asia-Pacific Recent Past, Current & Future Analysis for Liquid Biopsy by Offering - Assay Kits, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for Liquid Biopsy by Offering - Percentage Breakdown of Value Sales for Assay Kits, Instruments and Services for the Years 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Liquid Biopsy by Technology - Multi Gene Parallel Analysis and Single Gene Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for Liquid Biopsy by Technology - Percentage Breakdown of Value Sales for Multi Gene Parallel Analysis and Single Gene Analysis for the Years 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Liquid Biopsy by Application - Cancer and Non-Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for Liquid Biopsy by Application - Percentage Breakdown of Value Sales for Cancer and Non-Cancer for the Years 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Liquid Biopsy by End-Use - Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific 6-Year Perspective for Liquid Biopsy by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses for the Years 2025 & 2030

REST OF WORLD

Rest of World Recent Past, Current & Future Analysis for Liquid Biopsy by Offering - Assay Kits, Instruments and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of World 6-Year Perspective for Liquid Biopsy by Offering - Percentage Breakdown of Value Sales for Assay Kits, Instruments and Services for the Years 2025 & 2030

Rest of World Recent Past, Current & Future Analysis for Liquid Biopsy by Technology - Multi Gene Parallel Analysis and Single Gene Analysis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of World 6-Year Perspective for Liquid Biopsy by Technology - Percentage Breakdown of Value Sales for Multi Gene Parallel Analysis and Single Gene Analysis for the Years 2025 & 2030

Rest of World Recent Past, Current & Future Analysis for Liquid Biopsy by Application - Cancer and Non-Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of World 6-Year Perspective for Liquid Biopsy by Application - Percentage Breakdown of Value Sales for Cancer and Non-Cancer for the Years 2025 & 2030

Rest of World Recent Past, Current & Future Analysis for Liquid Biopsy by End-Use - Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of World 6-Year Perspective for Liquid Biopsy by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals & Physician Laboratories, Academic & Research Centers and Other End-Uses for the Years 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	% VALIDATED RESEARCH *
Apostle Inc	%
Biocept, Inc.	%
BioChain Institute, Inc.	%
Biolidics Ltd.	%
CatchGene	%
Civco Medical Solutions	%
Elphogene	%
F. Hoffmann-La Roche Ltd.	%
Guardant Health, Inc.	%
Hamilton Company	%

* Login to Participate & View Data Stacks

* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

Scroll